Skip to main content

Table

From: Ecological and economic impact of ceftazidime and probabilist antibiotherapy limitation strategy in ventilator-associated pneumonia

% Ps Ps Acinetobacter KES Staph
  aeruginosa cepacia baumanii   aureus
G1      
   Incidence 19 16.7 6 14.3 19
   CTZ-S 61 85 0 90 -
   AMK-S 55 0 40 83 -
   CPX-S 50 0 0 83 -
   OXA-S - - - - 30
G2      
   Incidence 13 11.5 3 23 -
   CTZ-S 85 100 33 94 -
   AMK-S 80 0 33 94 -
   CPX-S 40 0 0 88 -
   OXA-S - - - - 63
  1. Ps, Pseudomonas; KES, Klebsiella-Enterobacter-Serratia; Staph, Staphyloccocus; CTZ-S, ceftazidime-sensitive; AMK-S, amikacin-sensitive; CPX-S, ciprofloxacin-sensitive; OXA-S, oxacillin-sensitive.